LT

Lithuania

1537 clinical trials

Find Trials

Clinical Trials (1537)

Showing 20 of 1,537 trialsScroll for more
NCT00662740Phase 31 site

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

Terminated
NCT03486873Phase 33 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT04628026Phase 31 site

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

Recruiting
NCT04464226Phase 34 sites

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Active Not Recruiting
NCT05269004Phase 33 sites

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Active Not Recruiting
NCT06872892Phase 33 sites

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Recruiting
NCT07064473Phase 37 sites

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Recruiting
NCT07220915Phase 34 sites

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

Recruiting
NCT04597125Phase 44 sites

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Active Not Recruiting
NCT04957719Phase 34 sites

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

Enrolling By Invitation
NCT05581303Phase 36 sites

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Active Not Recruiting
NCT06124157Phase 21 site

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Recruiting
NCT06713837Phase 31 site

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Recruiting
NCT07012395Phase 23 sites

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Recruiting
NCT07299019Phase 31 site

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Recruiting
NCT07429214Not Applicable1 site

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

Active Not Recruiting
NCT07596849Phase 32 sites

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

Recruiting
NCT07652294Phase 23 sites

Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

Enrolling By Invitation
NCT04434092Phase 31 site

A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors

Active Not Recruiting